The MCP-1 promoter was found to be methylated in 8 out of 32 patients with T2DM and 12 out of 15 control individuals, suggesting that the MCP-1 promoter region was methylated primarily in control individuals compared with the patients with T2DM. The gene discussed is CCL2; the disease is type 2 diabetes mellitus.